Vanguard Group
ASTX

Vanguard Group’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Vanguard Group’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,404,209
Closed -$20.4M – 3954
2013
Q3 		$20.4M Buy
2,404,209
+1,685
+0.1% +$10.7K ﹤0.01% 2105
2013
Q2 		$9.87M Buy
+2,402,524
New +$12.9M ﹤0.01% 2337

Vanguard Group's ASTX Position: Q4 2013 in Review

Vanguard Group sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 2,404,209 shares — an estimated $20.4M sold.

Vanguard Group first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $20.4M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Vanguard Group reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Vanguard Group sold 2,404,209 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $20.4M.
  • Vanguard Group first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Vanguard Group's ASTEX PHARMACEUTICALS, INC COM position peaked at $20.4M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Vanguard Group's 13F filing for Q4 2013, filed 12 Feb 2014.